SCE Freiraum Ventures
VC Fund
Munich, Germany
SCE Freiraum Ventures is a venture capital investor focused on early-stage startups. We back teams and accompany them throughout their journey. We are experts in education and acceleration of early-stage teams. Our home is the Strascheg Center for Entrepreneurship (SCE), the Entrepreneurship Center of the Munich University of Applied Science(MUAS). Our fund is backed by Prof. Dr. Falk F. Strascheg – one of the most experienced and successful venture capitalists in Germany and Europe. He is a founding partner of EXTOREL Private Equity Advisers, a leading venture capital firm. Further information is available at: www.freiraum.vc
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries SCE Freiraum Ventures invests in
Stages SCE Freiraum Ventures invests in
Countries SCE Freiraum Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
|
Prof. Dr. Herbert Gillig
|
|||
|
Prof. Dr. Klaus Sailer
|
|||
Investment Focus
Industry
- Health Care 4 (67%)
- Software 2 (33%)
- Medical 1 (17%)
- Wellness 1 (17%)
- Simulation 1 (17%)
Country
- Germany 4 (67%)
- United Kingdom 2 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
David Photien
Investor
|
Investor | Total investments: 1 | Find email | |
|
Prof. Dr. Herbert Gillig
Head of New Venture Program
|
Head of New Venture Program | Total investments: 0 | Find email | |
|
Prof. Dr. Klaus Sailer
Investor
|
Investor | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Onyx Biotech is a biotech company that develops simulation-based digital twin software to optimize biopharmaceutical process engineering. | Pre-Seed / Apr 20, 2026 | |
|
|
ZERØTEC is an pattern design and nesting software platform for fashion designers and manufacturers | $739.6K / Pre-Seed / Oct 01, 2025 | |
|
|
Digitizing pulmonary rehabilitation to empower health professionals with AI, reduce their workload and enable them to provide better care for their patients. | $934.8K / Pre-Seed / Aug 29, 2025 | |
|
XenoPatch GmbH
|
First-ever portable device for pain management, seamlessly combines heat, cold and vibration treatment with an intuitive smartphone app. | Pre-Seed / Jul 17, 2024 | |
|
|
Voda is the LGBTQIA+ mental wellbeing app developed with leading LGBTQIA+ psychotherapists. We're on a mission to help members of the LGBTQIA+ community lead more fulfilled and thriving lives through affordable, accessible and intersectional digital therapy.Voda's self-guided therapy programs are up to 24x more affordable than privatetherapy. | $351.8K / Pre-Seed / Jun 06, 2024 | |
|
|
Traindoo enables physiotherapists and personal trainers to track customers digitally and online coaching for healthcare providers. | $518.1K / Pre-Seed / Nov 17, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does SCE Freiraum Ventures invest in?
SCE Freiraum Ventures invests primarily in Health Care, Software and Medical startups, most often at Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact SCE Freiraum Ventures?
Public channels for SCE Freiraum Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SCE Freiraum Ventures?
The team at SCE Freiraum Ventures includes David Photien (Investor), Prof. Dr. Herbert Gillig (Head of New Venture Program) and Prof. Dr. Klaus Sailer (Investor). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!